Macrophage migration inhibitory factor: A counter-regulator of glucocorticoid action and critical mediator of septic shock

被引:0
作者
Calandra, T [1 ]
Bucala, R [1 ]
机构
[1] PICOWER INST MED RES,MED BIOCHEM LAB,MANHASSET,NY 11030
关键词
MIF; glucocorticoids; macrophage; T cell; cytokine; septic shock; pituitary;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have led to the discovery of a mediator that acts as an endogenous counter-regulator of glucocorticoid action within the immune system. Isolated as a product of anterior pituitary cells, this protein was found to have the sequence of macrophage migration inhibitory factor (MIF), one of the first cytokine activities to be described. Macrophages and T cells release MIF in response both to various inflammatory stimuli and upon incubation with low concentrations of glucocorticoids. The glucocorticoid-induced secretion of MIF is tightly regulated and decreases at high, anti-inflammatory steroid concentrations. Once secreted, MIF ''overrides'' the anti-inflammatory and immunosuppressive effect; of steroids on macrophage and T-cell cytokine production. The physiological role of MIF thus appears to be to counter-balance steroid inhibition of the inflammatory response. Anti-MIF antibodies fully protect animals from experimentally induced gram-negative or gram-positive septic shock, an effect that may be the result of the increased anti-inflammatory effect of glucocorticoids after neutralization of endogenous MIF. Anti-MIF therapeutic strategies are presently under development and may prove to be a means to modulate cytokine production in septic shock as well as in other inflammatory disease states. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 53 条
[1]  
ARYA SK, 1984, J IMMUNOL, V133, P273
[2]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[3]   An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].
Bacher, M ;
Metz, CN ;
Calandra, T ;
Mayer, K ;
Chesney, J ;
Lohoff, M ;
Gemsa, D ;
Donnelly, T ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854
[4]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[5]   PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[6]   An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction [J].
Bernhagen, J ;
Bacher, M ;
Calandra, T ;
Metz, CN ;
Doty, SB ;
Donnelly, T ;
Bucala, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :277-282
[7]   ADRENALECTOMY SENSITIZES MICE TO THE LETHAL EFFECTS OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR [J].
BERTINI, R ;
BIANCHI, M ;
GHEZZI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (05) :1708-1712
[8]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[9]   RAT-LIVER PROTEIN LINKING CHEMICAL AND IMMUNOLOGICAL DETOXIFICATION SYSTEMS [J].
BLOCKI, FA ;
SCHLIEVERT, PM ;
WACKETT, LP .
NATURE, 1992, 360 (6401) :269-270
[10]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&